Clinical trials confirm these associations: in a phase II RCT, 6 months of moderate aerobic exercise reduced fasting insulin and HOMA-IR in colorectal cancer survivors, with greater benefits in those with higher exercise volumes (up to −20 pmol/L) (30). This evidence concerns the gene INS and colorectal cancer.